Madrigal Pharmaceuticals annual ebitda margin
2009
2010
2011
2012
2024
2025
Madrigal Pharmaceuticals EBITDA Margin Growth & History (MDGL)
Madrigal Pharmaceuticals's ebitda margin was −31.16% for fiscal 2025.
View full Madrigal Pharmaceuticals company overviewMadrigal Pharmaceuticals annual ebitda margin history
| Fiscal year | Period ended | EBITDA margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −31.16% | +244.63 pp |
| 2024 | 2024-12-31 | −275.78% | — |
| 2012 | 2012-12-31 | −40,954.42% | −40374.67 pp |
| 2011 | 2011-12-31 | −579.75% | −343.54 pp |
| 2010 | 2010-12-31 | −236.20% | −292.89 pp |
| 2009 | 2009-12-31 | 56.69% | — |
Madrigal Pharmaceuticals quarterly ebitda margin
Q3.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | EBITDA margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −15.35% | +6.65 pp |
| Q1 2026 | 2026-03-31 | −29.66% | +27.85 pp |
| Q4 2025 | 2025-12-31 | −18.44% | +46.05 pp |
| Q3 2025 | 2025-09-30 | −39.55% | +147.03 pp |
| Q2 2025 | 2025-06-30 | −22.00% | +1086.55 pp |
| Q1 2025 | 2025-03-31 | −57.51% | — |
| Q4 2024 | 2024-12-31 | −64.49% | — |
| Q3 2024 | 2024-09-30 | −186.58% | — |
| Q2 2024 | 2024-06-30 | −1,108.55% | — |
| Q1 2012 | 2012-03-31 | −9,751.70% | −8830.70 pp |
| Q4 2011 | 2011-12-31 | −292.55% | — |
| Q3 2011 | 2011-09-30 | −710.22% | −421.77 pp |
| Q2 2011 | 2011-06-30 | −857.39% | — |
| Q1 2011 | 2011-03-31 | −921.00% | — |
| Q3 2010 | 2010-09-30 | −288.44% | — |
Madrigal Pharmaceuticals ebitda margin trends
Between the periods ended 2009-12-31 and 2025-12-31, Madrigal Pharmaceuticals's ebitda margin decreased from 56.69% to −31.16%, a change of −87.84 percentage points. The latest reported quarter, Q2 2026, shows −15.35%.
About the metric
What EBITDA margin means
EBITDA margin measures EBITDA as a percentage of revenue. It can help compare operating profitability over time, but it excludes capital intensity, financing costs, taxes, and other items and is generally unsuitable for financial companies.
Calculation and source
How EBITDA margin is calculated
TickerStat calculates EBITDA margin as EBITDA divided by positive reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Madrigal Pharmaceuticals source filings ↗